Ground-Breaking New Study Challenges Causes of Heart Disease.
Disclaimer: The contents of this video are for informational purposes only and are not intended to be medical advice, diagnosis, or treatment, nor to replace medical care. The information presented herein is accurate and conforms to the available scientific evidence to the best of the author's knowledge as of the time of posting. Always seek the advice of your physician or other qualified health provider with any questions regarding any medical condition. Never disregard professional medical advice or delay seeking it because of information contained in Nutrition Made Simple!.
#Vitality40Plus #HealthyOver40 #FitOver40 #Over40Health
Video Summary
AI GeneratedA landmark clinical trial called Horizon, which tested the drug pelicarsin to lower Lipoprotein(a) [LPA] levels, has failed to show a significant reduction in cardiovascular events. This result is shocking to the scientific community because genetic evidence strongly suggests LPA is a causal driver of heart disease, not just a marker.